{
"id":"mk19_a_id_t63",
"number":63,
"bookId":"id",
"title":{
"__html":"Recommended Initial Laboratory Screening and Other Studies in Persons with HIV Infection"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"89230a",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 63. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_a_id_t63"
}
]
},
"Recommended Initial Laboratory Screening and Other Studies in Persons with HIV Infection"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0cbc66",
"class":"col hd l",
"children":[
"Test"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8413c6",
"class":"col hd l",
"children":[
"Comments"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"80f6e5",
"class":"col hd l",
"children":[
"HIV-specific tests for all persons with HIV"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d99e1a",
"class":"cell txt l",
"children":[
"HIV antigen/antibody testing"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"945e4c",
"class":"cell txt l",
"children":[
"If written evidence of diagnosis not available or if viral load low or undetectable"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1f969e",
"class":"cell txt l",
"children":[
"CD4 cell count and percentage"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5551f3",
"class":"cell txt l",
"children":[
"Assess need for opportunistic infection prophylaxis"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a5376b",
"class":"cell txt l",
"children":[
"Plasma HIV RNA polymerase chain reaction (HIV viral load)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6d8a48",
"class":"cell txt l",
"children":[
"Establish baseline and monitor viral suppression"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2ddb4c",
"class":"cell txt l",
"children":[
"HIV resistance testing"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"10db03",
"class":"cell txt l",
"children":[
"Baseline genotype for protease inhibitor, nonnucleoside RTI, nucleoside/nucleotide RTI mutations for persons who have never initiated therapy, are reengaging in care and not receiving therapy, or with inconsistent access to therapy. INSTI genotype is recommended only if suspicion for INSTI mutation transmission."
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"c6244f",
"class":"col hd l",
"children":[
"Other laboratory tests"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"00274a",
"class":"cell txt l",
"children":[
"Complete blood count with differential"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"decf91",
"class":"cell txt l",
"children":[
"Assess for anemia, neutropenia, thrombocytopenia"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"67e7f9",
"class":"cell txt l",
"children":[
"Alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e83a9b",
"class":"cell txt l",
"children":[
"Assess for evidence of liver damage, hepatitis, or systemic infection (e.g., elevated alkaline phosphatase level with some opportunistic infections)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"af1001",
"class":"cell txt l",
"children":[
"Total protein and albumin levels"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6e6901",
"class":"cell txt l",
"children":[
"High total protein level common with untreated HIV infection because of increased immunoglobulin fraction secondary to B-cell hyperplasia; low albumin level may indicate nutritional deficiency or nephrotic syndrome"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f69633",
"class":"cell txt l",
"children":[
"Electrolytes, blood urea nitrogen, creatinine"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2fd9db",
"class":"cell txt l",
"children":[
"Assess kidney function; creatinine level for calculation of estimated glomerular filtration rate"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e1ef9b",
"class":"cell txt l",
"children":[
"Lipid profile and blood glucose; hemoglobin A",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1c"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a52e24",
"class":"cell txt l",
"children":[
"Fasting not needed for initial lipid and glucose assessment; if abnormal, repeat fasting"
]
},
" ",
{
"type":"p",
"hlId":"4e875c",
"class":"cell txt l",
"children":[
"Hemoglobin A",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1c"
]
},
" measured before ART initiation but not used for diagnosis of diabetes in those taking ART"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_2-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"747c2a",
"class":"cell txt l",
"children":[
"Urinalysis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1519ff",
"class":"cell txt l",
"children":[
"Assess for evidence of proteinuria, hematuria"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"2"
},
"children":[
" ",
{
"type":"p",
"hlId":"0d592c",
"class":"col hd l",
"children":[
"Screening for coinfections"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"309e5c",
"class":"cell txt l",
"children":[
"Cervical Pap test"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e79d16",
"class":"cell txt l",
"children":[
"21-29 years of age: annual Pap test; if three consecutive Pap tests are normal, follow-up screening in 3 years."
]
},
" ",
{
"type":"p",
"hlId":"0678d7",
"class":"cell txt l",
"children":[
"â‰¥30 years of age: three consecutive normal Pap tests without an HPV test, follow-up Pap in 3 years; Pap with HPV testing are both negative, follow-up Pap in 3 years after combined test"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ca2f57",
"class":"cell txt l",
"children":[
"Anal Pap test",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1f0268",
"class":"cell txt l",
"children":[
"Anal Pap test for all persons with a history of receptive anal intercourse, genital warts, or abnormal cervical Pap result if access to appropriate referral for follow-up, including high-resolution anoscopy, is available"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"63bc9a",
"class":"cell txt l",
"children":[
"Gonorrhea, chlamydia"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8ae870",
"class":"cell txt l",
"children":[
"At least annual screening using nucleic acid amplification testing with sites based on exposure history (e.g., urine, vaginal, rectal, oropharyngeal; three-site testing preferred for all patients)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"44f3ef",
"class":"cell txt l",
"children":[
"Trichomoniasis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8e3a93",
"class":"cell txt l",
"children":[
"Annual screening in all persons who have vaginal sex"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fd36aa",
"class":"cell txt l",
"children":[
"Syphilis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"b0f648",
"class":"cell txt l",
"children":[
"At least annual screening using local protocol (either rapid plasma reagin or treponemal-specific antibody tests)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7a38d5",
"class":"cell txt l",
"children":[
"Latent ",
{
"type":"tag",
"tagName":"i",
"attrs":{
},
"children":[
"Mycobacterium tuberculosis"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1a74e6",
"class":"cell txt l",
"children":[
"TST or IGRA; IGRA preferred if history of BCG vaccination"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"498a7f",
"class":"cell txt l",
"children":[
"Varicella-zoster virus"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"69aaf9",
"class":"cell txt l",
"children":[
"Anti-varicella IgG if no known history of chicken pox or shingles"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26c139",
"class":"cell txt l",
"children":[
"Hepatitis A, B, and C virus"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d9bcca",
"class":"cell txt l",
"children":[
"HBsAg, HBsAb, HBcAb, HCVAb; HAV total or IgG antibody. If HBsAg+ or HBcAb+, order HBV DNA level; if HCVAb+, order HCV RNA level and HCV genotype. Screen for hepatocellular carcinoma for all adult patients with cirrhosis and noncirrhotic patients with chronic HBV for an extended period."
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_3-9 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"17c5e2",
"class":"cell txt l",
"children":[
"Measles titer"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"70d265",
"class":"cell txt l",
"children":[
"Adequate evidence of immunity includes being born in the United States before 1957, written documentation of adequate vaccination, or serologic evidence of immunity. Persons born in the 1960s may have been vaccinated with a vaccine other than MMR and may have waning immunity. Patients may opt to receive a booster MMR vaccine rather than check serology."
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"ART = antiretroviral therapy; BCG = bacillus Calmetteâ€“GuÃ©rin; HAV = hepatitis A virus; HBcAb = hepatitis B core antibody; HBsAb = hepatitis B surface antibody; HBsAg = hepatitis B surface antigen; HBV = hepatitis B virus; HCV = hepatitis C virus; HCVAb = hepatitis C antibody; HPV = human papillomavirus; IGRA = interferon-Î³ release assay; INSTI = integrase strand transfer inhibitor; MMR = measles, mumps, rubella; RTI = reverse transcriptase inhibitor; TST = tuberculin skin test."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"At this time, no national guidelines are available for this intervention."
],
[
"Adapted with permission from Thompson MA, Horberg MA, Agwu AL, et al. Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2020 Nov 6:ciaa1391. Epub ahead of print. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33225349",
"target":"_blank"
},
"children":[
"PMID: 33225349"
]
},
" doi: 10.1093/cid/ciaa1391"
]
]
}